Software & Services
Myob Group Ltd (ASX:MYO) (FRA:7MY) has been an innovative software company since 1991, and provides tools to over a million enterprises and accountants to help improve their business performance and effectiveness. Through innovation, MYOB has been able to consistently grow and maintain its position as a market leader in Australia and New Zealand.
iSignthis Ltd (ASX:ISX) are pleased to provide an analyst brief presented at Hong Kong - April 2016.
iSignthis Ltd (ASX:ISX) has received executed access agreements, and also finalised and tested its technical integration with Yeepay, and its subsidiary the Beijing Yi HuiJin Information Service Co. Ltd.
Xped Limited (ASX:XPE) today announced the appointment of Dr. Wenjun Sheng as a Non-Executive Director of the company, effective from today 21 April, 2016.
Xped Ltd (ASX:XPE) is pleased to announce that it has entered into a Heads of Agreement with the shareholder of JCT Healthcare Pty Ltd and Jackson Care Technologies Pty Ltd to acquire all of the issued capital in JCT (JCT Acquisition or the Transaction).
With the ADRC software supporting prototype demonstrations, XPED Ltd (ASX:XPE) is expanding its reach and penetration in the IoT ecosystem; we are engaging prospective industrial customers in commercial and market trials. The company has established a number of Memorandum of Understanding (MOU's).
Xped Limited (ASX:XPE) is delighted to announce that Xped's ADRC technology will soon be compatible and available on the "Intel(R) IoT Gateway". Intel customers will have access to all the benefits that ADRC technology provides, including NFC on-boarding of devices with a simple tap.
Xped Ltd (ASX:XPE) ("Xped" or "the Company") wishes to announce that Xped Holdings Limited has received an official "notice of patent grant right" for the flagship ADRC patent from the China Patent Office on March 29th 2016.
Xped Limited (ASX:XPE) wishes to announce that is has acquired a 35% interest in Vital Xense Pte Ltd a Singapore based company with a focus on designing and distributing sensor and related equipment to customers in its region.
Xped Limited (ASX:XPE) wishes to announce that Xped Holdings Limited and a leading US listed technology company have entered into a Memorandum of Understanding (MOU) to identify and develop potential business transactions utilizing XPED's patented Auto Discovery Remote Control (ADRC) Technology.
Banking & Finance
- Locksley Resources Limited (ASX:LKY) Qualifies for Trading on U.S. OTCQX Market
- Resolution Minerals Ltd (ASX:RML) OTCQB Listing Successfully Completed
- VIDEO: Lion Selection Group Ltd (ASX:LSX) CEO Hedley Widdup and Sean Russo Talk at the Australian Gold Conference 2024
- VIDEO: The Australian Gold Conference 2024 - Education Evening with Expert Panel
- Lithium Universe Ltd (ASX:LU7) Finalises Frankfurt and US OTC Listing
- ISX Financial Reports Strong Q2 2024 Results, Highlighting Robust Growth and Innovation
Oil Gas & Energy
- Central Petroleum Limited (ASX:CTP) Cooper and Otway Basin Transaction Unconditional
- Deep Yellow Limited (ASX:DYL) Managing Director and CEO Commencement Date
- Deep Yellow Limited (ASX:DYL) Exploration Update
- Central Petroleum Limited (ASX:CTP) Appoints Mr Joel Riddle as Director
- Central Petroleum Limited (ASX:CTP) Strategic Expansion Into the Cooper and Otway Basins
- Beetaloo Energy Australia Limited (ASX:BTL) Carpentaria-5H Flow Testing Update
Life Sciences
- Proteomics International Laboratories Ltd (ASX:PIQ) Canadian Patent Secured for PromarkerEso Test for Esophageal Adenocarcinoma
- Proteomics International Laboratories Ltd (ASX:PIQ) Appointment of CEO and Managing Director
- BPH Energy Limited (ASX:BPH) Raises $1.2M to Accelerate Funding of Hydrocarbon and Cortical Investments
- Proteomics International Laboratories Ltd (ASX:PIQ) US Lab Accredited by College of American Pathologists - Extends Precision Dx Lab
- Proteomics International Laboratories Ltd (ASX:PIQ) US Patent Secured for PromarkerEso Diagnostic Test for Throat Cancer
- Proteomics International Laboratories Ltd (ASX:PIQ) PromarkerD Changes How Doctors Manage Diabetic Kidney Disease - Study Published

























